Omalizumab In The Treatment Of Refractory Urticarial Vasculitis Triggered By SARS-Cov-2 Infection: A Pediatric Case Report. Dermatology Practical & Conceptual, [S. l.], v. 14, n. 4, p. e2024252, 2024. DOI: 10.5826/dpc.1404a252. Disponível em: https://dpcj.org/index.php/dpc/article/view/4512.. Acesso em: 3 dec. 2024.